Ping An Biomedical FY26 first-half net income turns to RMB 4.83 million; revenue falls 47.38% to RMB 9.59 million
PASW•Balance sheet position
Cash and bank balances increased to RMB 6.84 million as of March 31, 2026, while total assets climbed to RMB 100.22 million.
First-half results improve to profit
Ping An Biomedical swung to net income of RMB 4.83 million for the six months ended March 31, 2026, from a net loss a year earlier.
Revenue fell 47.38% to RMB 9.59 million, while operating income turned positive at RMB 537,604.
Earnings per share and other income rise
Basic and diluted earnings per share swung to RMB 0.10 from a loss a year earlier.
Other income rose to RMB 5.75 million, including a RMB 5.67 million fair-value gain on equity investments.
